ESR1 and hepatocellular carcinoma: To evaluate if the downmodulation in Wnt/β-catenin signaling identified by gene expression affected HCC cell proliferation, mice treated with ER-α agonist were evaluated for β-catenin, cyclin-D1 and Ki67 IHC staining as a reflection of tumor proliferation rate in comparison to controls.